Physician profile
Matthew Arnold
NPI 1992476444
$1,591.83
in general payments reported to CMS, 2019-2025
12 companies · $939 in 2025
The $939 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.98 · 2023: $172 · 2024: $466 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $708.05 | 2022-2025 | Solitaire X, Pipeline, Axium Primetm |
| Route 92 Medical, INC. | $307.58 | 2024-2025 | 8f Base Camp Sheath System |
| Microvention, INC. | $248.42 | 2024-2025 | Stent, Web Aneurysm Embolization System, V-Grip Detachment Controller |
| Boston Scientific Corporation | $84.44 | 2024-2025 | General - Vascular Intervention, Opticross 35, Accolade Sr |
| Stryker Corporation | $47.44 | 2025 | Surpass Evolve |
| Imperative Care, INC | $41.82 | 2024 | Zoom 88-T Large Distal Platform |
| Asahi Intecc USA, INC. | $36.72 | 2024-2025 | Peripheral Vascular, Asahi Interventional Radiology Wires |
| Cardiva Medical, INC. | $32.10 | 2025 | Cardiva Vascade 6/7f Vcs |
| Becton, Dickinson and Company | $26.95 | 2025 | Pleurx |
| Depuy Synthes Sales INC. | $24.05 | 2024 | Trufill |
| Polynovo North America LLC | $19.93 | 2025 | Novosorb Btm |
| Bard Peripheral Vascular, INC. | $14.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.